Clinical trial
The Detour Endovascular Technique for Long OcclUsive Fem-pop Revascularization - 2 Clinical Trial
NCT03119233 is registered in ClinicalTrials.gov with Endologix as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Detour Endovascular Technique for Long OcclUsive Fem-pop Revascularization - 2 Clinical Trial
- Lead sponsor
- Endologix
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 13, 2017
- Completion date
- November 13, 2023
- Enrollment
- 202 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.